Celyad Oncology SA

CYAD.BR | EURONEXT | 0 Sledující

€0.38

8.57%

€0.03

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 EUR	12/31/2023 EUR	12/31/2022 EUR	12/31/2021 EUR
Total revenue	186 +82.35%	102 -	0 -	0 -
Cost of revenue	-733 -1,162.32%	69 -95.21%	1,440 -5.26%	1,520 -
Gross profit	919 +2,684.85%	33 +102.29%	-1,440 +5.26%	-1,520 -
Operating expense	7,178 -15.45%	8,490 -58.10%	20,263 -24.70%	26,909 -
Operating income	-6,259 +25.99%	-8,457 +79.30%	-40,857 -54.81%	-26,391 -
Pretax Income	-5,960 +29.97%	-8,511 +79.18%	-40,870 -54.21%	-26,502 -
Tax Provision	-136 +28.80%	-191 -393.85%	65 +550.00%	10 -
Net income	-5,824 +31.06%	-8,448 +79.36%	-40,935 -54.40%	-26,512 -
EPS	-0.14 +57.58%	-0.33 +81.77%	-1.81 -6.47%	-1.7 -
Diluted EPS	-0.14 +57.58%	-0.33 +81.77%	-1.81 -6.47%	-1.7 -
Average Shares	41,429 +61.06%	25,722 +13.84%	22,594 +44.80%	15,604 -
Diluted Average Shares	41,429 +61.06%	25,722 +13.84%	22,594 +44.80%	15,604 -
EBIT	-5,841 +31.74%	-8,557 +79.20%	-41,135 -52.73%	-26,934 -
EBITDA	-5,391 +30.56%	-7,763 +80.44%	-39,695 -56.19%	-25,414 -

Soubory cookie používáme ke zlepšení prohlížení na webu.